Evidence map›Paper›PMID 19455132›Full record

Trial reportThe American journal of gastroenterology2009

A treatment trial of acupuncture in IBS patients.

Anthony J Lembo, Lisa Conboy, John M Kelley, Rosa S Schnyer, Claire A McManus, Mary T Quilty, Catherine E Kerr, Doug Drossman, Eric E Jacobson, Roger B Davis

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in The American journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 11 pooled it
44.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 11 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Pooled it
  10. Acupuncture for treatment of irritable bowel syndrome.The Cochrane database of systematic reviews · 2012
    Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2018
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Anthony J LemboThe Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb/Rose 1, Boston, MA 02215, USA. alembo@bidmc.harvard.edu
Lisa Conboy
John M Kelley
Rosa S Schnyer
Claire A McManus
Mary T Quilty
Catherine E Kerr
Doug Drossman
Eric E Jacobson
Roger B Davis
Harvard University · USHarvard University Press · USBeth Israel Deaconess Medical Center · US

Funding

ZINC STATUS AND T CELL DISORDER IN MILD HUMAN ZINC DEFICIENCYM01RR001032 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PASCUAL-LEONE, ALVARO · 1985 to 2008
$32.3M
Enhancing the Placebo Effect in Irritable Bowel SyndromeR01AT001414 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KAPTCHUK, TED · 2003 to 2006
$2.5M
Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · HARVARD MEDICAL SCHOOL · PI KAPTCHUK, TED · 2007 to 2016
$1.4M
Patient Variables and Placebo Responses in IBSR21AT002564 · NCCIH · MASSACHUSETTS GENERAL HOSPITAL · PI ABLON, J STUART · 2005 to 2006
$411k
Integrative Healing Model in IBS (RMI)R21AT002860 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KAPTCHUK, TED · 2004 to 2005
$254k
NCCIH NIH HHS 1K24 AT 004095NCCIH NIH HHS 1R01 AT 001414-01NCCIH NIH HHS 1 R21 AT 002564NCCIH NIH HHS 1R21 AT 002860-01NCCIH NIH HHS K24 AT004095NCCIH NIH HHS R01 AT001414NCCIH NIH HHS R21 AT002860NCRR NIH HHS M01 RR001032NCRR NIH HHS RR 01032
6 · The paper itself

Abstract

objectivesThis study aimed to compare the effects of true and sham acupuncture in relieving symptoms of irritable bowel syndrome (IBS).

methodsA total of 230 adult IBS patients (75 % females, average age: 38.4 years) were randomly assigned to 3 weeks of true or sham acupuncture (6 treatments) after a 3-week "run-in" with sham acupuncture in an "augmented" or "limited" patient-practitioner interaction. A third arm of the study included a waitlist control group. The primary outcome was the IBS Global Improvement Scale (IBS-GIS) (range: 1 - 7); secondary outcomes included the IBS Symptom Severity Scale (IBS-SSS), the IBS Adequate Relief (IBS-AR), and the IBS Quality of Life (IBS-QOL).

resultsAlthough there was no statistically significant difference between acupuncture and sham acupuncture on the IBS-GIS (41 vs. 32 % , P = 0.25), both groups improved significantly compared with the waitlist control group (37 vs. 4 % , P = 0.001). Similarly, small differences that were not statistically significant favored acupuncture over the other three outcomes: IBS-AR(59 vs. 57 % , P = 0.83), IBS-SSS (31 vs. 21 % , P = 0.18), and IBS-QOL (17 vs. 13 % , P = 0.56). Eliminating responders during the run-in period did not substantively change the results. Side effects were generally mild and only slightly greater in the acupuncture group.

conclusionsThis study did not find evidence to support the superiority of acupuncture compared with sham acupuncture in the treatment of IBS.

Indexed as

Acupuncture TherapyAdultDouble-Blind MethodFemaleFollow-Up StudiesHumansInflammatory Bowel DiseasesMalePatient SatisfactionPhysician-Patient RelationsProspective StudiesTreatment Outcome

Identifiers

PMID19455132
PMCPMC2694961
OpenAlexW1990925727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.